Amy Amick, CEO of Aspirion (Columbus, Ga.), has significantly impacted the company since taking the helm. In her first year, she led Aspirion to over 30% organic growth and spearheaded an aggressive mergers and acquisitions strategy, establishing the company as a leader in denials management.
Amick’s focus on client excellence, AI-driven innovation, and scalability has not only driven substantial organic growth but also facilitated the successful integration of three strategic acquisitions. These efforts have enhanced revenue recovery for provider partners and fostered sustained success and growth.
Her leadership has been instrumental in restoring financial stability for hospitals still recovering from the Covid-19 pandemic. Under her guidance, Aspirion earned the Best in KLAS Denials Management Award, reflecting the company’s excellence in the field.
Before joining Aspirion, Amick held several leadership positions in the healthcare industry. These include CEO and president at SPH Analytics, president of revenue cycle at MedAssets, COO at MedQuist/M*Modal, general manager at Microsoft Health Solutions Group, and senior vice president at Mysis/Allscripts.
Read full Becker’s Hospital Review article.